LTRN

Lantern Pharma Inc. (LTRN) is an innovative clinical-stage biotechnology company based in Dallas, Texas, specializing in precision oncology through the integration of artificial intelligence and genomics. By leveraging its proprietary technology platform, Lantern Pharma accelerates drug discovery by accurately targeting oncology treatments to specific tumor genetic profiles, enhancing therapeutic effectiveness and patient outcomes. Committed to a data-centric approach, the company aims to transform cancer therapy and address the diverse needs of patient populations, positioning itself as a pivotal player in the evolving landscape of cancer treatment.